# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 bill...
Wells Fargo Investment Institute has a 4600-4800 year-end 2024 target for the S&P 500 Index and 2000-2200 for the MSCI EAFE...
While the markets are focussing on the October jobs report missing expectations, here's a missing piece that may prove them...
A proposed regulatory shift has injected uncertainty into the laboratory-testing market just as startups advance various tests ...
Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&...
The National Institutes of Health (NIH) has halted a trial evaluating the safety and effectiveness<
-Reuters